Navigation Links
ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line
Date:11/5/2009

rmoGenesis markets through independent distributors. The MXP is used for isolating stem cells from bone marrow.
  • The Res-Q(TM) 60 BMC (Res-Q), a point of care system that is designed for bone marrow stem cell processing. This product was launched in July 2009.
  • The CryoSeal® FS System, an automated device and companion sterile blood processing disposable, is used to prepare fibrin sealants from plasma in about an hour. The CryoSeal FS System is approved in the U.S. for liver resection surgeries. The CryoSeal FS System has received the CE-Mark which allows sales of the product throughout the European community. Asahi Medical is the exclusive distributor for the CryoSeal System in Japan and the Company markets through independent distributors in Europe and South America.
  • This press release contains forward-looking statements, and such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for fiscal years 2010, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2010. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Sec
    '/>"/>

    SOURCE ThermoGenesis Corp.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Thermogenesis Corp. to Announce First Quarter Fiscal 2010 Results on November 5, 2009
    2. ThermoGenesis Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
    3. ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results
    4. ThermoGenesis Announces Expanded Collaboration With Celling Technologies
    5. ThermoGenesis Provides Update on Fiscal 2009 Results
    6. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
    7. ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall
    8. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
    9. ThermoGenesis Presentation at Rodman & Renshaw Conference
    10. ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008
    11. ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)...  Neurotech Pharmaceuticals, Inc., announced today the first ... 2 clinical trial of NT-503 Encapsulated Cell Therapy ... choroidal neovascularization secondary to age related macular degeneration ... growth factor (VEGF) receptor protein continuously produced by ... proof-of-concept study will evaluate NT-503 ECT as a ...
    (Date:9/2/2015)... ZIONA, Israel , September 2, 2015 /PRNewswire/ ... today announced the intent of the National Institute of Allergy ... of Health (NIH) within the Department of Health and Human ... be held in the United States ... of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as a ...
    (Date:9/2/2015)... ... 02, 2015 , ... The TS5-Q is designed for myriad ... to analysis of athletic performance. Producing high-resolution slow-motion video , the TS5-Q ... process with the naked eye. , Slow motion sequences are commonly seen ...
    (Date:9/1/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... Annual Global Investment Conference sponsored by H.C. Wainwright ... The St. Regis Hotel in New York, ... , Chief Executive Officer, will provide an overview of ...
    Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
    ... 19 DuPont Chairman and,CEO Charles O. Holliday, Jr., ... will enable the world to keep pace with the ... materials. "Biotechnology is the most powerful tool available ... said. "It holds the promise,to deliver the world more, ...
    ... Oct. 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ... specialty pharmaceutical and,medical device company, today announced ... September 30, 2007 and updated its financial,outlook ... 2007, in conjunction with the,release of Boston ...
    ... Ltd (SWX: ATLN) today,announced multiple presentations regarding ... the efficacy and safety of Tracleer in,combination ... first 1,500,patients with pulmonary arterial hypertension (PAH) ... And Long-term PAH Disease,Management) Registry. The presentations ...
    Cached Biology Technology:Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 3Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 4Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 5Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 6Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 7Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 8Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 9Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 10Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 11Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007 2Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007 3
    (Date:8/26/2015)... PUNE, India , August 26, 2015 ... (Two, Three, Four, and Five Factor), Application (Travel & ... and Geography - Global Forecast to 2020", published by ... 9.60 Billion by 2020, growing at a CAGR of ... 71 Tables and 82 F igures spread through ...
    (Date:8/20/2015)... , Aug. 20, 2015 The ... consumers that are active and healthy. However, wearable ... the hospital environment to help improve diagnostic capabilities ... video from the Wearable Technologies Conference 2015 ... new applications for wearables in healthcare.    ...
    (Date:8/18/2015)... Aug. 18, 2015  Navitas today announced ... to the Submission Content Management webinar scheduled ... non-profit forum. Dedicated to the Implementation of Regulatory ... platform for industry, vendors, health authorities, consultants ... work towards a standard method of implementing ...
    Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
    ... been studying the rare and threatened bonobo ape will lead monitoring ... wild in the Congo for the first time this month. ... group of 18 orphan bonobos will be returned to the wild. ... the bonobos as they adjust to life back in the wild," ...
    ... States must be careful that the new emphasis on ... into account potential damage to the nation,s water resources. ... have far-reaching environmental and economic repercussions, and it will ... and water security," said a report titled "The Water ...
    ... microtubules might be responsible for some cases of the neurological ... June 15, 2009 issue of the Journal of Cell ... microtubules too stable to perform their jobs, the researchers find. ... their strength, or both. One of these mutations leads to ...
    Cached Biology News:Duke, Harvard researchers to monitor bonobo reintroduction 2Rice University researchers ask if biofuels will lead to a 'drink or drive' 2